PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands j.s.demaar@umcutrecht.nl.\', \'Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.\', \'Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.\', \'Department of Anesthesiology, University Medical Center Utrecht, Utrecht, The Netherlands.\', \'Department of Surgical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1136/bmjopen-2020-040162
?:doi
?:hasPublicationType
?:journal
  • BMJ open
is ?:pmid of
?:pmid
?:pmid
  • 33243800
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.372
?:rankingScore_hIndex
  • 57
?:title
  • Phase I feasibility study of Magnetic Resonance guided High Intensity Focused Ultrasound-induced hyperthermia, Lyso-Thermosensitive Liposomal Doxorubicin and cyclophosphamide in de novo stage IV breast cancer patients: study protocol of the i-GO study.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all